{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:05:04Z","timestamp":1789625104340,"version":"build-2803163510"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Natural Science Foundation of Hunan Provincial","award":["2022JJ40755"],"award-info":[{"award-number":["2022JJ40755"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,21]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>As one of the primary composite endpoints in cardiovascular clinical research, major adverse cardiac events (MACE) are associated with poor clinical outcomes in patients with cardiovascular diseases. Gut microbiota and immune cells are increasingly recognized to be associated with MACE. However, the precise mechanisms remain unclear. We retrospectively analyzed the global burden of ischemic heart disease (IHD) and ischemic stroke (IS), 2 major contributors to the overall burden of MACE, by extracting data from the Global Burden of Disease database, and two-sample Mendelian randomization (MR) using the FinnGen R9 I9_CHD dataset as the outcome to investigate the genetically predicted associations between gut microbiota, immune cell traits, and major coronary heart disease events. In 2021, global IHD prevalence reached 254.3 million cases, a 1.4% increase from 1990, whereas IS prevalence declined by 39.6% over the same period. Results of Mendelian randomization analysis provided evidence supporting genetically predicted associations between 21 gut microbiota, 31 immune cells, and major coronary heart disease event. Sensitivity tests confirmed our findings. Additionally, mediation analysis suggested that the association between gut microbiota and major coronary heart disease event may be partly mediated through immune cell traits. Our study provides both an updated epidemiological profile of IHD\/IS and genetic evidence linking gut microbiota and immune cell traits to coronary events, with immune cells potentially acting as mediators. These findings provide a foundation for future mechanistic studies and may facilitate the identification of candidate therapeutic targets, although further experimental validation is required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050188","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T17:06:05Z","timestamp":1787331965000},"page":"e50188","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Gut microbiota, immune cell traits, and major adverse cardiac events"],"prefix":"10.1097","volume":"105","author":[{"given":"Jia","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxi","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Changsha Hospital of Traditional Chinese Medicine, Changsha, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8203-925X","authenticated-orcid":false,"given":"Lixiong","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260917","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1213\/ANE.0b013e3181b7908c","article-title":"Postoperative activity, but not preoperative activity, of antithrombin is associated with major adverse cardiac events after coronary artery bypass graft surgery.","volume":"111","author":"Garvin","year":"2010","journal-title":"Anesth Analg"},{"key":"R2-20260917","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1186\/s13063-022-06977-4","article-title":"Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights.","volume":"23","author":"Marsal","year":"2022","journal-title":"Trials"},{"key":"R3-20260917","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1001\/jama.2013.278787","article-title":"Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents.","volume":"310","author":"Hawn","year":"2013","journal-title":"JAMA"},{"key":"R4-20260917","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jbi.2017.01.001","article-title":"MACE prediction of acute coronary syndrome via boosted resampling classification using electronic medical records.","volume":"66","author":"Huang","year":"2017","journal-title":"J Biomed Inform"},{"key":"R5-20260917","doi-asserted-by":"crossref","first-page":"e00036","DOI":"10.1128\/MMBR.00036-17","article-title":"The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota.","volume":"81","author":"Milani","year":"2017","journal-title":"Microbiol Mol Biol Rev"},{"key":"R6-20260917","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jare.2022.06.008","article-title":"Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction patients different from stable coronary artery disease.","volume":"46","author":"Dong","year":"2023","journal-title":"J Adv Res"},{"key":"R7-20260917","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1161\/CIRCRESAHA.122.319983","article-title":"Aging microbiota-gut-brain axis in stroke risk and outcome.","volume":"130","author":"Honarpisheh","year":"2022","journal-title":"Circ Res"},{"key":"R8-20260917","doi-asserted-by":"crossref","first-page":"e004947","DOI":"10.1161\/JAHA.116.004947","article-title":"Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies.","volume":"6","author":"Heianza","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R9-20260917","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13054-020-02989-1","article-title":"The gut microbiome\u2019s role in the development, maintenance, and outcomes of sepsis.","volume":"24","author":"Adelman","year":"2020","journal-title":"Crit Care"},{"key":"R10-20260917","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1126\/science.aad9378","article-title":"How colonization by microbiota in early life shapes the immune system.","volume":"352","author":"Gensollen","year":"2016","journal-title":"Science"},{"key":"R11-20260917","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3390\/nu13020699","article-title":"Nutritional components in western diet versus Mediterranean diet at the gut microbiota-immune system interplay. implications for health and disease.","volume":"13","author":"Garc\u00eda-Montero","year":"2021","journal-title":"Nutrients"},{"key":"R12-20260917","first-page":"14","article-title":"Interaction between the gut microbiome and mucosal immune system.","volume":"4","author":"Shi","year":"2017","journal-title":"Mil Med Res"},{"key":"R13-20260917","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1097\/CM9.0000000000002875","article-title":"Regulatory T cells and cardiovascular diseases.","volume":"136","author":"Hu","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"R14-20260917","doi-asserted-by":"crossref","first-page":"e45714","DOI":"10.1097\/MD.0000000000045714","article-title":"Explore the relationships between gut microbiota and cardiomyopathies with the potential mediating effect of cytokines: a univariable and multivariable Mendelian randomization study.","volume":"104","author":"Guo","year":"2025","journal-title":"Medicine (Baltim)"},{"key":"R15-20260917","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat Genet"},{"key":"R16-20260917","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41588-021-00991-z","article-title":"Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort.","volume":"54","author":"Qin","year":"2022","journal-title":"Nat Genet"},{"key":"R17-20260917","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1177\/0962280215597579","article-title":"A review of instrumental variable estimators for Mendelian randomization.","volume":"26","author":"Burgess","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"R18-20260917","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R19-20260917","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R20-20260917","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R21-20260917","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"R22-20260917","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40168-019-0683-9","article-title":"Alterations in the gut microbiome and metabolism with coronary artery disease severity.","volume":"7","author":"Liu","year":"2019","journal-title":"Microbiome"},{"key":"R23-20260917","doi-asserted-by":"crossref","first-page":"680101","DOI":"10.3389\/fmicb.2021.680101","article-title":"Dysbiosis of gut microbiota in patients with acute myocardial infarction.","volume":"12","author":"Han","year":"2021","journal-title":"Front Microbiol"},{"key":"R24-20260917","first-page":"2128","article-title":"Impact of immunity on coronary artery disease: an updated pathogenic interplay and potential therapeutic strategies.","volume":"13","author":"Laera","year":"2023","journal-title":"Life (Basel)"},{"key":"R25-20260917","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/s13063-017-2210-2","article-title":"CXCR2 inhibition - a novel approach to treating CoronAry heart DiseAse (CICADA): study protocol for a randomised controlled trial.","volume":"18","author":"Joseph","year":"2017","journal-title":"Trials"},{"key":"R26-20260917","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis.","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ Res"},{"key":"R27-20260917","doi-asserted-by":"crossref","first-page":"15662","DOI":"10.3390\/molecules181215662","article-title":"Stimulation of natural killer T cells by glycolipids.","volume":"18","author":"Anderson","year":"2013","journal-title":"Molecules"},{"key":"R28-20260917","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/01.sla.0000219039.20924.88","article-title":"Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial.","volume":"244","author":"Sugawara","year":"2006","journal-title":"Ann Surg"},{"key":"R29-20260917","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1900997","article-title":"Probiotics reduce self-reported symptoms of upper respiratory tract infection in overweight and obese adults: should we be considering probiotics during viral pandemics?","volume":"13","author":"Mullish","year":"2021","journal-title":"Gut Microbes"},{"key":"R30-20260917","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/gut.52.2.237","article-title":"Alterations of the dominant faecal bacterial groups in patients with Crohn\u2019s disease of the colon.","volume":"52","author":"Seksik","year":"2003","journal-title":"Gut"},{"key":"R31-20260917","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/art.34595","article-title":"Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis.","volume":"64","author":"Mikuls","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R32-20260917","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41581-018-0018-2","article-title":"The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease.","volume":"14","author":"Yang","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"R33-20260917","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"R34-20260917","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12967-020-02539-x","article-title":"Gut microbiota from coronary artery disease patients contributes to vascular dysfunction in mice by regulating bile acid metabolism and immune activation.","volume":"18","author":"Liu","year":"2020","journal-title":"J Transl Med"},{"key":"R35-20260917","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/CIRCULATIONAHA.118.035235","article-title":"Loss of gut microbiota alters immune system composition and cripples postinfarction cardiac repair.","volume":"139","author":"Tang","year":"2019","journal-title":"Circulation"},{"key":"R36-20260917","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/eurheartj\/ehab644","article-title":"Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism.","volume":"43","author":"Haghikia","year":"2022","journal-title":"Eur Heart J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:01:18Z","timestamp":1789624878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050188"}},"subtitle":["A joint analysis of global burden of disease study and Mendelian randomization"],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":36,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050188","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"2026-03-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}